Kovsan J, Bashan N, Greenberg AS, Rudich A. Potential role of autophagy in modulation of lipid metabolism. Am J Physiol Endocrinol Metab 298: E1-E7, 2010. First published November 3, 2009 doi:10.1152/ajpendo.00562.2009.-Autophagy is a major degradative pathway(s) by which intracellular components are delivered into the lysosomes. It is largely implicated in determining cell death and survival because it eliminates unnecessary, damaged, and/or potentially harmful cellular products and organelles and is an important source for nutrients and energy production under conditions of external nutrient deficiency. As such, autophagy has been suggested to contribute to the regulation of carbohydrate and protein metabolism during fasting. Recently, three papers implicated a role for autophagy in cellular lipid metabolism as well. This Perspectives article presents these novel findings in the context of prior studies on the role of autophagy and lysosomes in metabolic and energy regulation, discusses their points of agreement and opposing propositions, and outlines key outstanding questions.
Autophagy: the Process of Self-Digestion
LYSOSOMES ARE CELLULAR ORGANELLES responsible for an important portion of the degradative activity that is necessary for maintaining cellular homeostasis and defense (7) . Recycling of plasma membrane proteins and their ligands is targeted into lysosomes by the endosomal pathway when destined for degradation; extracellular pathogens reach lysosomes for destruction as part of cellular defense via fusion of phagosomes with lysosomes (18) ; and intracellular components that need to be degraded, either since they are dysfunctional or to meet cellular energetic or metabolic demands, reach lysosomes by several pathways collectively termed autophagy (13, 53) .
The highly evolutionarily conserved macro-autophagy pathway classically involves the generation of a phospholipid bilayer endomembrane (phagophore), which sequesters cytosolic components, including cytoplasm and organelles (autophagosome), to then mature and acidify while fusing with lysosomes (autolysosome). As such, macro-autophagy is largely viewed as a nonselective process. Yet, eukaryotic cells demonstrate various degrees of selectivity in targeting intracellular components to autophagosomes by distinct autophagic pathways. These include chaperone-mediated autophagy, micro-autophagy, and organelle-directed autophagy, such as mitophagy (further discussed below), although the mechanisms for selectivity are incompletely understood. The reader is referred to excellent reviews describing these specific pathways in more detail (9, 34, 53) .
Clearly, these processes are highly complex and regulated and involve a large family of effector proteins, many of which belong to the Atg's (autophagy-related genes), initially identified in yeast (40) . These are involved in targeting cargo into autophagosomes, in autophagosome membrane biosynthesis, elongation and fusion processes, in vesicle acidification, etc. Many of those are essential for the process to occur. For example, LC-3 (mammalian Atg8 ortholog) and the Atg12-Atg5-Atg16 complex function as ubiquitin-like protein-conjugating systems that facilitate phagophore membrane elongation (15) . Both are activated by Atg7 and form protein complexes with two E2-like enzymes: Atg3 and Atg10, respectively. In addition, the regulation of the process involves PI 3-kinases (type I inhibit, type III activate autophagy), their downstream effectors, and various small GTPases that participate in maturation steps of the autophagosomes (4, 41) . A detailed molecular description of the autophagic machinery is summarized in a recent review (53) .
Autophagy Beyond Cell Death and Survival: Evidence for Involvement in Metabolic Regulation
As a "self-digestion" process, autophagy has been extensively studied in the context of cell survival and death, being a strategy to overcome severe nutrient deficiency but also a mechanism for cell death when the process is overwhelming and/or fails to meet the initiating challenge (14, 17, 27, 45) . Nevertheless, autophagy has also been implicated to play significant roles in metabolic and energy regulation even during physiological conditions, contributing to carbohydrate and protein homeostasis. Simplistically, as a process involved in catabolic conditions, autophagy is expected to be inhibited by feeding and activated by fasting (4), during which it contributes to stored fuel breakdown and utilization (Fig. 1) . It is therefore not surprising that insulin is a major hormonal suppressor of autophagy, via a process likely dependent on the intracellular generation of phosphatidylinositol 3,4,5-trisphosphate (PIP 3 ) (35, 41) , the second messenger of most (if not all) of insulin's metabolic actions. The robust suppressive effect of insulin on autophagy likely accounts for the nearly complete absence of autophagosomes in livers of mice refed after a 48-h fasting period (39) . Likewise, insulin may regulate diurnal cycles in autophagy flux, which in rat liver peaks at the end of the fasting period (light phase) and is minimal after refeeding, although direct regulation of autophagy by circadian clock genes has been also proposed (44) . During prolonged fasting (starvation), autophagy exhibits a tonic elevated level even before circulating insulin levels completely lose diurnal fluctuations. These suggest that, under starvation conditions, pos-sibly distinctly from "physiological fasting," other factors like amino acids and glucagon could contribute to the regulation of autophagic flux (Ref. 44 and references therein).
The following sections briefly describe the potential contribution of autophagy to carbohydrate homeostasis, to the regulation of protein metabolism, and to the regulation of mitochondrial mass.
Carbohydrate homeostasis. Autophagy has been proposed to contribute to glycogenolysis flux, complementing the canonical cytosolic breakdown of glycogen by glycogen phosphorylase and the debranching enzyme (26) . In cardiac muscle of newborn mice, glycogen content is very high but progressively falls after birth, coinciding with the appearance of glycogencontaining autophagic vacuoles (8, 25) . Similarly, glucagon and adrenalin enhance the breakdown of cardiac muscle glycogen while increasing autophagic activity and the number, size, and total volume of glycogen-containing autophagic vacuoles, along with an elevated activity of acid glucosidase (lysosomal glycogen-hydrolyzing enzyme) (24) . Fasting for 12-72 h may also induce autophagosome formation in cardiomyocytes (50) , and the cardioprotective effect of aerobic training has been suggested to be mediated by increased autophagic capacity in cardiomyocytes (16, 32 ). Yet, this latter effect may be more related to the elimination of dysfunctional mitochondria (see Mitochondrial mass) than to the breakdown of glycogen (38) . It was initially thought that, in the liver, autophagy is required for glycogen breakdown to support glucose production in the neonatal period, since Atg5-and Atg7-null mice exhibit increased sensitivity to fasting in the neonatal period (23, 29) . However, whether hypoglycemia was the cause of the neonatal death, and even if so, whether impaired glycogenolysis or deficient gluconeogenesis due to impaired amino acid mobilization is the cause of hypoglycemia (see Protein metabolism), remains unsettled (29, 46) .
The importance of lysosomal glycogenolysis specifically for skeletal and cardiac muscle is highlighted in humans by the clinical manifestation of acid maltase deficiency (glycogen storage disease type II, OMIM 232300). In this disorder, Fig. 1 . Contribution of autophagy and/or other lysosmal compartments to glycogen and protein breakdown and the regulation of mitochondrial mass during fasting. During prolonged fasting, most tissues switch to ATP production by oxidizing free fatty acids (FFA) released by adipose tissue via the breakdown of stored triglycerides (lipolysis). The brain remains dependent on glucose utilization, requiring endogenous glucose production, predominantly by the liver. Endogenous glucose production is supported by glycogen breakdown (during earlier phases of the fasting period) and later by the energy-requiring gluconeogenesis (GNG) pathway. For the latter, energy is generated by mitochondrial ␤-oxidation of FFA, whereas the carbon sources for glucose are amino acids (mainly from skeletal muscle) and glycerol (the product of adipocyte lipolysis). It is proposed that autophagy and/or lysosmal-related processes are involved in 1) glycogen breakdown [complementing its cytosolic breakdown by glycogen phosphorylase (GP) and the debranching enzyme], Lysosomal glycogen breakdown may also occur during fasting in the heart, but for its own ATP generation (rather that for glucose production). 2) proteolysis, the breakdown of proteins into amino acids, mainly in skeletal muscle; and 3) degradation of mitochondria (mitophagy), likely ridding the cells of inefficient and/or damaged mitochondria, mainly in liver and the heart. glycogen accumulates in lysosomes, and the main manifestations are cardiomegaly, heart failure, and hypotonia but, interestingly, not hypoglycemia. Autophagy as the means of introducing glycogen into the lysosomal compartment is highlighted by Danon's disease (OMIM 309060), a condition in which lysosome-associated membrane protein-2 (LAMP2), a protein involved in autophagosome maturation, is mutated. This condition shows similar manifestations to acid maltase deficiency, but glycogen accumulates in autophagosomes that fail to fuse with lysosomes (33) . The absence of hypoglycemia in these disorders raises the intriguing possibility that autophagy could play a significant role in liver glycogenolysis in the neonatal period (at least in mice, likely not in humans), whereas later in life autophagy-mediated glycogenolysis mainly contributes to cardiac and skeletal muscle energy utilization.
Protein metabolism. During fasting, protein breakdown mainly in skeletal muscle is required to generate the carbon source for gluconeogenesis. Gluconeogenesis in the liver (and in the kidney) is required to maintain euglycemia, particularly in the intermediate fasting period (Ͼ8 h and Ͻ48 -72 h in humans). Under these conditions, hepatic (and kidney) glycogen stores have already been exhausted, whereas liver ketogenesis and ketone utilization by the brain and peripheral tissues for energy production have not yet reached full capacity. The proteasomal protein degradation machinery, a cytosolic process, has been considered the major mechanism for protein breakdown during fasting, based on the use of inhibitors and gene expression analyses (30) . The latter demonstrate elevated expression of ubiquitin and proteasomal subunits, particularly the proteasome-specific E3, atrogin-1 (19) . Nevertheless, of the more minor proteolytic processes that also include calpains and caspases, lysosomal pathways were estimated to contribute 10 -20% of the total proteolytic capacity in skeletal muscle (2, 37 ). Yet, in C 2 C 12 myotubes, lysosomal proteolysis was estimated to account for 40% of total protein breakdown, whereas the proteasome accounted for 50% (55) . FoxO3 seems to specifically activate lysosomal proteolysis in these cells, as lysosomal inhibitors blocked 70% of the increase in proteolytic activity observed in myotubes infected with a virus encoding a constitutively active FoxO3 (55, 56) . Thus, autophagy may be a significant contributor to protein breakdown during prolonged (Ͼ24 h) fasting and/or other conditions with low Akt (and thus high FoxO) regulatory input.
Mitochondrial mass. As in carbohydrate and protein metabolism, autophagy may complement additional degradative pathways that regulate mitochondrial mass (20) . Autophagyrelated elimination of mitochondria and/or mitochondrial components, either by nonselective macro-autophagy and/or by a selective process that targets dysfunctional mitochondria (mitophagy) (36), has been described in yeast but also in mammalian cells, in particular hepatocytes (31, 42) . Although how dysfunctional mitochondria are identified and targeted for autophagy-related elimination is not entirely understood, the process in hepatocytes may involve the "mitochondrial permeability transition" (10); however, in cardiomyocytes, swollen and enlarged mitochondria may escape mitophagy (6) . Interestingly, glucagon was proposed more than 30 years ago to induce autophagic elimination of mitochondria in hepatocytes (1) . When coupled to nutrient deprivation, the process in hepatocytes appears to be facilitated by the reduced activity of the antiautophagic type I PI 3-kinase input (the consequence of low insulin) but increased activity of proautophagic type III PI 3-kinase. Overall, it may reach a rate of 1% of the mitochondria per hour, particularly targeting depolarized mitochondria (10) . A similar process has been proposed in the heart in response to aerobic exercise (16) .
Although the phenomenon of increased mitophagy in hepatocytes under conditions that mimic fasting is rather well described, the physiological rationale behind it is not entirely clear. Eliminating damaged mitochondria that may be potentially harmful is clearly in "the best interest" of any cell under most physiological settings. It is possible that glucagon and oxidative nutrient processing in the liver during fasting increases the number of depolarized and/or otherwise dysfunctional mitochondria and their accelerated rate of elimination is thus secondary. Alternatively, increased autophagic capacity may precede or occur independently of changes in mitochondrial function, rendering mitophagy activation during fasting the primary process. Regardless, once fully degraded, metabolites that are produced by mitochondria breakdown could directly fuel ATP generation in the liver and/or provide direct substrates (amino acids) for biosynthetic pathways such as gluconeogenesis.
Potential Contribution of Autophagy to Lipid Metabolism
In addition to the above-mentioned involvement of autophagy in energy and metabolic regulation during fasting, three recently published papers now suggest two different potential roles for autophagy (or components of its machinery) in lipid metabolism, two in nonadipocytes, and, very recently, in preadipocytes (Fig. 2) .
The paper by Singh et al. (48) suggests that lipid droplets (LD) can be degraded in hepatocytes by a specific autophagyrelated process, "lipo(macro)autophagy" or lipophagy, digesting this storage cytosolic organelle much as mitophagy and pexophagy regulate mitochondria and peroxisome turnover, respectively. Both autophagy and lipolysis are processes activated under nutrient deficiency (i.e., fasting), and both have been known to be inhibited by the major anabolic hormone insulin. Yet, lipolysis has been largely viewed, at least in adipocytes, to be regulated by cytosolic lipases and their interaction with LD-associated proteins, like perilipin and fat-specific protein-27; CIDEC (cell death-inducing DFFA-like effector protein C), which determine their activity and access to the LD triglyceride core (3). Thus, the major novelty of that study was in suggesting that incorporation of LD into autophagosomes is required for triglyceride breakdown and that this pathway of lipolysis may be regulated under physiolgocial (increased exposure of fatty acids like oleic acid) and pathophysiological (high-fat feeding) conditions.
The study by Shibata et al. (47) suggests an alternative role for components of the autophagic machinery in lipid metabolism in nonadipocytes. During fasting, autophagy-related protein LC3, microtubule-associated protein light chain 3 (LC3) cleavage is proposed to be necessary for LD biogenesis in hepatocytes and cardiomyocytes rather than for LD breakdown. Cleaved (and lipidated) LC3 could be demonstrated on isolated LD from these cells. Moreover, in the absence of Atg7 specifically in hepatocytes, LD formation during fasting was significantly inhibited. A potential explanation for these findings is that LC3 is involved in LD biogenesis as part of a nonautophagic function of this protein (LC3 cleavage has also been shown to be required for vesicle hemifusion (22)). Yet, the reliance on Atg, and the morphological assessment mentioned above strongly suggest an overlap between LC3-assisted newly formed LD and autophagosomes.
As frequently occurs, the two papers used different experimental approaches in their studies, which may underlie different conclusions. This is particularly true for the field of autophagy, in which diverse methodologies exist, each with its advantages and potential artifacts (21) . Nevertheless, their apparently contradicting propositions on the potential role of autophagy in lipid metabolism are most strongly highlighted by the use of one similar experimental design, the use of Atg7-deficient hepatocytes. Singh et al. (48) observed an increased number of LD and lipid accumulation (consistent with its role in LD breakdown), whereas Shibata et al. (47) reported decreased amount of lipid and LD upon fasting (consistent with a role for Atg7 in LD biogenesis). Clearly, specific experimental details may underlie this discrepancy, but future studies will have to sort out this contradiction, possibly offering a complex role for Atg7. Despite this, it is of interest that the two studies addressed lipid metabolism in nonadipocytes, although adipocytes are the cells most dedicated to lipid storage and mobilization and most specialized in responding to the fed-fasting state. This raises the question of whether autophagy also regulates lipid metabolism in adipocytes, a question of importance given the centrality of this process in human health and disease (54) .
In a very recent study, autophagy was demonstrated to regulate adipogenesis (the differentiation process of preadipocytes into mature adipocytes) (49) . Pharmacological or genetic inhibition of autophagy in preadipocytes in vitro, or adipocytespecific Atg7-null mice, demonstrated that intact autopahgy is required for the development of white adipose tissue. When autophagy was impaired, adipogenesis was affected, yielding a mouse with lower fat mass, but also to an adipogenic process that favored the generation of brown adipose tissue. Moreover, even white adipose tissue fat cells exhibited characteristics typical of brown adipocytes, such as smaller cell size, multiple LD per cell, and increased number of mitochondria and expression of UCP1. Altohugh this study suggests a newly unidentified role for autophagy in regulating preadipocyte differentiation and potentially the trans-differentiation of white to brown-like adipocytes, it also raises the possibility that autophagy is in fact required for LD biogenesis, somewhat consistent with the propositions made by Shibata et al. in liver and cardiac cells (47) . Whether this is also true in the fully differentiated "mature" adipocyte awaits future studies, but the adipogenic transcription factor PPAR␥ may be a linker between autophagy and adipogenesis, as in cancer cells a PPAR␥ agonist activated the autophagic machinery (57).
Autophagy and Lipid Metabolism: Outstanding Questions
Multiple outstanding questions emerge from the concept that autophagy may be involved in lipid homeostasis, and two will be discussed below.
What is the relative role of autophagy in lipid handling in adipocytes vs. nonadipocytic cells? As described above, autophagy complements additional degradative pathways involved in carbohydrate, protein, and mitochondrial elimination, such as the proteasome. Thus, the relative contribution of autophagy to these processes remains a challenging issue to define, as it may vary in different physiological or pathophysiological conditions, and between different cell types. Cytosolic lipases like hormone-sensitive lipase (HSL) are expressed at much higher levels in adipocytes than in other cell types. Likewise, the repertoire of LD-associated proteins may differ between adipocytes (in which perilipin is the major LD-associated protein) and other cell types [(that mainly express adipose differentiation-related protein (ADRP)] (3). Thus, it is plausible that under physiological conditions lipophagy is a process for LD handling by nonadipocytes, whereas adipocytes can rely on the well-described regulation of lipolysis by cytosolic lipases and LD-associated proteins. However, in response to the HIV protease inhibitor nelfinavir, lipolysis is elevated in adipocytes because of enhanced protein degradation of perilipin, which occurred via a lysosome-related process (28) . Moreover, even in untreated 3T3-L1 adipocytes, lysosomal, but not proteasomal, inhibitors elevated the protein content of perilipin (28) . Since that study used inhibitors of acidification or of lysosomal proteases to block lysosome-related proteolysis, it fell short of clearly implicating autophagy in the regulation of perilipin protein content and, thereby, of lipolysis. Moreover, even if an autophagy process was involved, it remains unclear whether perilipin reached lysosomal-related compartment(s) by a process reminiscent of macroautophagy or rather utilized a more specific process, like chaperone-mediated autophagy or the somewhat less clearly defined micro-autophagy. Nevertheless, that study in adipocytes suggests that lysosome-related proteolysis regulates lipolytic flux from adipocytes by affecting the stability of perilipin, and this effect may or may not be accompanied by lysosomal lipolysis.
Other important possibilities to consider are that autophagy may contribute to LD biogenesis during adipogenesis, as was proposed to occur in hepatocytes and cardiomyocytes under fasting conditions (47) or in differentiating preadipocytes (49) . Alternatively, even if autophagy does not contribute significantly to adipocyte lipolysis in physiological states, it may contribute to elevated lipolysis in pathophysiolgical conditions. In obesity, cell hypertrophy along with blunted response to classical lipoytic stimuli (like adrenaline) may stress the adipocyte, saturating the lipolytic capacity via "physiological pathways" that activate cytosolic lipases. Under these circumstances, autophagy may be activated in response to the various adipose tissue stresses that were shown to occur in obesity (43) or reflect a new manifestation of insulin resistance, being less responsive to the inhibitory effect of insulin on autophagy. Autophagy may then either serve to limit adipocyte hypertrophy and protect the adipocyte from cell disruption as a result of excessive lipid storage or as a mechanism for cell death of hypertrophic adipocytes, which has been documented in obesity (5). Defining such a role for autophagy in adipocytes will be necessary when one considers manipulating this process for relieving metabolic consequences of obesity.
Does autophagy introduce a physiological role for a "new" lipase in the regulation of lipolysis?. If, as proposed by Singh et al. (48) , the triglycerides of LD are degraded by autphagosomes, which is the responsible lipase for triglycerides within the lysosome or autophagosome? Lysosomes contain acid lipase (EC 3.1.1.13), which in principle should break down neutral lipids that enter the lysosomal compartment, in particular, endocytosed lipoproteins. Consistently, deficiency in acid lipase causes Wolman disease (or cholesterol ester storage disease, OMIM 278000), a disorder characterized by massive hepatosplenomegaly due to accumulation mainly of cholesteryl ester but also of triglycerides. Intriguingly, fasting hypoglycemia, a frequent manifestations of disorders of impaired supply to or utilization of free fatty acids by the liver, is not usually reported among the many manifestation of the disease. Thus, although not conclusive, this observation does not support a major role for acid lipase in maintaining free fatty acid flux from adipose tissue during fasting.
Another intriguing possibility to consider is the ill-characterized Atg15 (also Cvt17 in yeast). The gene product is the only known autophagy-related protein with lipase activity and, intriguingly, the only autophagy gene shown to relate to life span (51) . By sequence comparison, the protein is predicted to hydrolyze neutral lipids like triglycerides. Yet, the Cvt17-delta yeast strain exhibits impaired ability to degrade membranebound vesicles, suggesting phospholipase activity to be necessary for membrane lipid breakdown (11, 12, 52) . Thus, the role of Atg15 as an autophagy-specific triglyceride lipase that could contribute to lipid breakdown, whether in adipocytes or nonadipocytes, awaits future research.
Concluding Remarks
Autophagy (and/or other lysosome-related organelles) has been shown to complement "classical pathways" in the catabolism of carbohydrates, protein, and mitochondria, particularly during fasting and nutrient deficiency. It is now proposed that autophagy, or members of its machinery, participates also in the regulation of lipid metabolism. Defining the relative contribution of these processes and exactly how they regulate lipid metabolism, particularly under pathophysiological states and in which cell types, will now be required before one considers the potential therapeutic implications of this added new knowledge.
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